En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood & Blood Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Point-Of-Care Testing

Browse Products by Category

Close

Hemex Health

Hemex Health

Hemex Health breaks traditional barriers with its innovative diagnostic system that expands the potential of diagnostics for important conditions, making accurate tests accessible to new locations and new populations. Hemex Health designs diagnostic technologies for the real world by listening to the needs of healthcar ...
Products Covid-19NewsSummary
Close

Covid-19 Hemex Health

Clinical Laboratory

Gazelle COVID-19 Test
COVID-19 Rapid Test

The Gazelle COVID-19 Test is portable, lightweight test detects all COVID-19 variants in 20 seconds from nasal swab samples with 99.4% accuracy compared to the gold standard, PCR. The test includes a fluorescent lateral flow immunoassay (FIA) and the Gazelle reader that utilizes image-recognition software for detection of nucleocapsid protein from SARS-CoV-2. The reader uses AI imaging and signal-to-noise enhancement techniques to achieve near-PCR accuracy.
More details

Point-Of-Care Testing

Gazelle COVID-19 Test
COVID-19 Rapid Test

The Gazelle COVID-19 Test is portable, lightweight test detects all COVID-19 variants in 20 seconds from nasal swab samples with 99.4% accuracy compared to the gold standard, PCR. The test includes a fluorescent lateral flow immunoassay (FIA) and the Gazelle reader that utilizes image-recognition software for detection of nucleocapsid protein from SARS-CoV-2. The reader uses AI imaging and signal-to-noise enhancement techniques to achieve near-PCR accuracy.
More details
Close

News of Hemex Health

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

14 Oct 2025
Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
A strategic collaboration aims to improve outcomes for millions with sickle cell disease and other hemoglobin disorders.
Read More
Close

About Hemex Health

Hemex Health breaks traditional barriers with its innovative diagnostic system that expands the potential of diagnostics for important conditions, making accurate tests accessible to new locations and new populations. Hemex Health designs diagnostic technologies for the real world by listening to the needs of healthcare providers including those in some of the most remote and challenging settings.

Recently updated

Point-Of-Care Reader
Gazelle

Gazelle is an inexpensive, portable, and easy-to-use diagnostic device that provides affordable, accurate testing to new populations at sites where it is needed most. The compact, rugged, battery-operated in vitro diagnostic device is used inexpensively, with no cold chain requirements, by entry level healthcare workers in areas with limited access, resources, or electricity. Patient information and results are captured digitally for storage, printing, or later transmission. Initial tests include sickle cell disease, beta thalassemia, and COVID-19.
More details

Gazelle COVID-19 Test
COVID-19 Rapid Test

The Gazelle COVID-19 Test is portable, lightweight test detects all COVID-19 variants in 20 seconds from nasal swab samples with 99.4% accuracy compared to the gold standard, PCR. The test includes a fluorescent lateral flow immunoassay (FIA) and the Gazelle reader that utilizes image-recognition software for detection of nucleocapsid protein from SARS-CoV-2. The reader uses AI imaging and signal-to-noise enhancement techniques to achieve near-PCR accuracy.
More details

SCD & Beta Thalassemia Test
Gazelle Hb Variant

The Gazelle Hb Variant Test, one of the tests supported by the Gazelle diagnostic platform, can detect Sickle Cell Disease (SCD) and beta thalassemia. As an affordable, portable, point-of-care test, Gazelle’s results are equivalent to standard lab tests but do not require complex logistical support. Administration of the test requires minimal training and results are displayed in eight minutes, including hemoglobin percentages by type, and can be stored locally or transmitted to the Cloud for patient and disease tracking.
More details

Clinical Laboratory

Point-Of-Care Reader
Gazelle

Gazelle is an inexpensive, portable, and easy-to-use diagnostic device that provides affordable, accurate testing to new populations at sites where it is needed most. The compact, rugged, battery-operated in vitro diagnostic device is used inexpensively, with no cold chain requirements, by entry level healthcare workers in areas with limited access, resources, or electricity. Patient information and results are captured digitally for storage, printing, or later transmission. Initial tests include sickle cell disease, beta thalassemia, and COVID-19.
More details

Gazelle COVID-19 Test
COVID-19 Rapid Test

The Gazelle COVID-19 Test is portable, lightweight test detects all COVID-19 variants in 20 seconds from nasal swab samples with 99.4% accuracy compared to the gold standard, PCR. The test includes a fluorescent lateral flow immunoassay (FIA) and the Gazelle reader that utilizes image-recognition software for detection of nucleocapsid protein from SARS-CoV-2. The reader uses AI imaging and signal-to-noise enhancement techniques to achieve near-PCR accuracy.
More details

SCD & Beta Thalassemia Test
Gazelle Hb Variant

The Gazelle Hb Variant Test, one of the tests supported by the Gazelle diagnostic platform, can detect Sickle Cell Disease (SCD) and beta thalassemia. As an affordable, portable, point-of-care test, Gazelle’s results are equivalent to standard lab tests but do not require complex logistical support. Administration of the test requires minimal training and results are displayed in eight minutes, including hemoglobin percentages by type, and can be stored locally or transmitted to the Cloud for patient and disease tracking.
More details

Point-Of-Care Testing

Point-Of-Care Reader
Gazelle

Gazelle is an inexpensive, portable, and easy-to-use diagnostic device that provides affordable, accurate testing to new populations at sites where it is needed most. The compact, rugged, battery-operated in vitro diagnostic device is used inexpensively, with no cold chain requirements, by entry level healthcare workers in areas with limited access, resources, or electricity. Patient information and results are captured digitally for storage, printing, or later transmission. Initial tests include sickle cell disease, beta thalassemia, and COVID-19.
More details

Gazelle COVID-19 Test
COVID-19 Rapid Test

The Gazelle COVID-19 Test is portable, lightweight test detects all COVID-19 variants in 20 seconds from nasal swab samples with 99.4% accuracy compared to the gold standard, PCR. The test includes a fluorescent lateral flow immunoassay (FIA) and the Gazelle reader that utilizes image-recognition software for detection of nucleocapsid protein from SARS-CoV-2. The reader uses AI imaging and signal-to-noise enhancement techniques to achieve near-PCR accuracy.
More details

SCD & Beta Thalassemia Test
Gazelle Hb Variant

The Gazelle Hb Variant Test, one of the tests supported by the Gazelle diagnostic platform, can detect Sickle Cell Disease (SCD) and beta thalassemia. As an affordable, portable, point-of-care test, Gazelle’s results are equivalent to standard lab tests but do not require complex logistical support. Administration of the test requires minimal training and results are displayed in eight minutes, including hemoglobin percentages by type, and can be stored locally or transmitted to the Cloud for patient and disease tracking.
More details
Copyright © 2000-2026 TradeMed.com. All rights reserved. | Terms And Conditions